TORL-4-500

· TORL Biotherapeutics, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TORL-4-500, covering 2025-03-04 to 2025-03-04. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer [Phase 1]